Dechra Veterinary Products Europe

Dechra Veterinary Products Europe is owned by Dechra Pharmaceuticals.

Dechra Pharmaceuticals is one of the...

• FTSE 350.

Dechra Pharmaceuticals is a company listed under the stock ticker DPH (GB).

Dechra Pharmaceuticals has a direct presence in 3 countries.

Acquisition, funding and merger involving Dechra Pharmaceuticals.

• EQT has announced the acquisition of Dechra Pharmaceuticals  (posted on June 7 2023).

View the org chart displaying its 2 main executives

Most searched biographies at Dechra Veterinary Products Europe

• Tony Griffin, Managing Director
• Karin Bay Andersen, Senior Manager Regulatory Affairs

Create your alert
to follow the executive moves at Dechra Veterinary Products Europe.

Dechra Pharmaceuticals has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Lucia Aleotti - Director at Menarini Group

Learn more about the Pharmaceuticals industry >

Press releases by Dechra Veterinary Products Europe

• Biofilm; beïnvloedt de prestaties van uw dieren
• Biofilm; vermindert de prestaties van dieren.

Social media about Dechra Veterinary Products Europe

• Dechra Veterinary Products Europe on Wikipedia, Google News & Yahoo Finance
• Dechra Veterinary Products Europe on LinkedIn, Twitter & YouTube

Contact by email its executives including Tony Griffin

Call Dechra Veterinary Products Europe at +31 49...

View the org chart

Register to receive your alert

Report an error